Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Cancer Immunotherapy in New Zealand | Fight Cancer |
Description | Treatment with Find out about a treatment option for cancers such as melanoma, non-small cell lung cancer, oesophageal cancer, renal cell carcinoma, and |
Keywords | N/A |
WebSite | fightcancer.co.nz |
Host IP | 75.2.28.153 |
Location | United States |
Site | Rank |
US$1,344,162
Last updated: 2023-05-11 18:03:41
fightcancer.co.nz has Semrush global rank of 7,874,278. fightcancer.co.nz has an estimated worth of US$ 1,344,162, based on its estimated Ads revenue. fightcancer.co.nz receives approximately 155,096 unique visitors each day. Its web server is located in United States, with IP address 75.2.28.153. According to SiteAdvisor, fightcancer.co.nz is safe to visit. |
Purchase/Sale Value | US$1,344,162 |
Daily Ads Revenue | US$1,241 |
Monthly Ads Revenue | US$37,223 |
Yearly Ads Revenue | US$446,676 |
Daily Unique Visitors | 10,340 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
fightcancer.co.nz. | A | 300 | IP: 75.2.28.153 |
fightcancer.co.nz. | A | 300 | IP: 99.83.146.123 |
fightcancer.co.nz. | NS | 86400 | NS Record: ns-1313.awsdns-36.org. |
fightcancer.co.nz. | NS | 86400 | NS Record: ns-1882.awsdns-43.co.uk. |
fightcancer.co.nz. | NS | 86400 | NS Record: ns-420.awsdns-52.com. |
fightcancer.co.nz. | NS | 86400 | NS Record: ns-734.awsdns-27.net. |
fightcancer.co.nz. | TXT | 300 | TXT Record: google-site-verification=qPUTjQswOvxofBMNK6GsDF-F_YGD2grZB2ik_KpdHyQ |
fightcancer.co.nz. | TXT | 300 | TXT Record: v=spf1 -all |
fightcancer.co.nz. | TXT | 300 | TXT Record: 9g5y075x7zrx46gd6sfbyb92k280st63 |
Types of Cancer Melanoma Lung cancer Classical Hodgkin lymphoma Urothelial carcinoma including bladder cancer Head and neck squamous cell cancer MSI-H/dMMR cancer Renal cell carcinoma Oesophageal cancer Endometrial carcinoma Triple-negative breast cancer Cervical cancer Understanding Immunotherapy About KEYTRUDA Access KEYTRUDA For Healthcare Professionals Treatment with KEYTRUDA KEYTRUDA may be used to treat patients with certain types of cancer. It is known as an immunotherapy and works by helping your immune system detect and fight your cancer. Read more KEYTRUDA may be used to treat patients with the following types of cancers Melanoma Melanoma KEYTRUDA is funded (restrictions apply), in adults with melanoma that has spread or cannot be removed by surgery. KEYTRUDA may be used, but is not funded, in certain adults and children with melanoma given after surgery to prevent the cancer from coming back. Read more Non-small cell lung cancer Non-small cell lung cancer KEYTRUDA is funded |
HTTP/1.1 301 Moved Permanently Server: awselb/2.0 Date: Tue, 09 Nov 2021 09:00:49 GMT Content-Type: text/html Content-Length: 134 Connection: keep-alive Location: https://www.fightcancer.co.nz:443/ HTTP/2 200 content-type: text/html;charset=UTF-8 date: Tue, 09 Nov 2021 09:00:50 GMT set-cookie: AWSALBTG=qvnvuUPmjJtNnwMFlFBVNqzYXdS0AfgqUy7gZ3rMnr7Iu3yY9lH44tiy7f83+yApVxHNCjXBYPZ+OjdTn1igUkznT4PbiG75evk1fOoT/Xs5o2nMX8BJFqbqUbZwStdq7UpWRjTIXinuoBs5EOlnNCktsk9VHMppXkj5QAIeDsY9bt0Igig=; Expires=Tue, 16 Nov 2021 09:00:50 GMT; Path=/ set-cookie: AWSALBTGCORS=qvnvuUPmjJtNnwMFlFBVNqzYXdS0AfgqUy7gZ3rMnr7Iu3yY9lH44tiy7f83+yApVxHNCjXBYPZ+OjdTn1igUkznT4PbiG75evk1fOoT/Xs5o2nMX8BJFqbqUbZwStdq7UpWRjTIXinuoBs5EOlnNCktsk9VHMppXkj5QAIeDsY9bt0Igig=; Expires=Tue, 16 Nov 2021 09:00:50 GMT; Path=/; SameSite=None; Secure set-cookie: AWSALB=2okIkauO4ApnoBFRjqm7XCzhvsBOSHtk3DgCIKWTKxVyANK5f/tIOI2jLA8/sgiCDO/PwCqDjuIvKbGfgBgC69GLbiPsWeQ1TfQbKZhRioZimFhRRUV1JYuOO8X/; Expires=Tue, 16 Nov 2021 09:00:50 GMT; Path=/ set-cookie: AWSALBCORS=2okIkauO4ApnoBFRjqm7XCzhvsBOSHtk3DgCIKWTKxVyANK5f/tIOI2jLA8/sgiCDO/PwCqDjuIvKbGfgBgC69GLbiPsWeQ1TfQbKZhRioZimFhRRUV1JYuOO8X/; Expires=Tue, 16 Nov 2021 09:00:50 GMT; Path=/; SameSite=None; Secure server: Apache x-frame-options: SAMEORIGIN, SAMEORIGIN referrer-policy: origin-when-cross-origin feature-policy: vibrate 'none' vary: Referer,Accept-Encoding cache-control: private, no-store, no-cache, must-revalidate pragma: no-cache expires: Thu, 01 Jan 1970 00:00:00 GMT set-cookie: JSESSIONID=100BF88B6BE02D5F743DB09B01EBFACB; Path=/; Secure; HttpOnly set-cookie: svcacess=a0df87f03eeeae3cc6a7d4b0115f2dfc; Path=/; Secure x-xss-protection: 1; mode=block x-content-type-options: nosniff set-cookie: oam.Flash.RENDERMAP.TOKEN=-m7kist3kg; Path=/foundation content-security-policy: frame-ancestors 'self' *.epublishmerck.com facebook.com; strict-transport-security: max-age=31536000 x-cache: Miss from cloudfront via: 1.1 dad289b00682a96e4153dd7ef9e7def3.cloudfront.net (CloudFront) x-amz-cf-pop: ORD53-C3 x-amz-cf-id: k4er8BCCZTf3MM_LsaKN65QOJDCtbBE1DkWu55tiavK3YVVJVE6x4Q== |
version: 8.7 query_datetime: 2021-11-09T21:52:31+13:00 domain_name: fightcancer.co.nz query_status: 200 Active domain_dateregistered: 2016-02-05T11:21:52+13:00 domain_datelastmodified: 2021-01-03T23:08:32+13:00 domain_datecreated: 2016-02-05T11:21:52+13:00 domain_delegaterequested: yes domain_signed: no registrar_name: MarkMonitor Inc. registrar_address1: 2150 S Bonito Way registrar_address2: Suite 150 registrar_city: Meridian registrar_province: Idaho registrar_postalcode: 83642 registrar_country: US (UNITED STATES) registrar_phone: +1 208 3895740 registrar_fax: +1 208 3895771 registrar_email: ccops@markmonitor.com ns_name_01: ns-734.awsdns-27.net ns_name_02: ns-1313.awsdns-36.org ns_name_03: ns-1882.awsdns-43.co.uk ns_name_04: ns-420.awsdns-52.com |